Single-Chamber Prefilled Syringes Market Overview 2024-2033 - Share, Trends, Demand, Outlook: Unraveling Key Drivers and Market Research Insights

The single-chamber prefilled syringes market size has grown rapidly in recent years. It will grow from $9.74 billion in 2023 to $11 billion in 2024 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to growth in pharmaceutical and biotechnology sectors, patient-friendly drug administration, safety and ease of use, demand for precise drug dosing, regulatory approvals and guidelines..

The single-chamber prefilled syringes market size is expected to see rapid growth in the next few years. It will grow to $19.22 billion in 2028 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to biologics and biosimilars in prefilled syringes, self-administration and home healthcare, pediatric and geriatric drug delivery, combination products with auto-injectors, regulatory emphasis on drug safety, telemedicine and remote monitoring.. Major trends in the forecast period include prefilled syringes with connected devices, sustainable and biodegradable materials, customized and patient-specific syringe options, needlestick prevention and safety features, prefilled syringes for cell and gene therapies, prefilled syringes with anti-counterfeiting measures..

Market Overview -
Single-chamber prefilled syringes are types of syringes that come with the substance to be injected prefilled. These contain a single type of substance.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=5419&type=smp

Rising Prevalence Of Chronic Diseases Fuels Single-Chamber Prefilled Syringes Market Growth
The growing prevalence of chronic diseases such as diabetes and cancer are contributing to the growth of the single-chamber prefilled syringe market. Diabetes patients who require insulin therapy when medicines cannot control their blood glucose levels use the single-chamber prefilled syringe. According to the IDF Diabetes Atlas 2021, an organization that promotes diabetes care, prevention, and a cure worldwide, 1 in 10 individuals (20-79 years old) have diabetes, which affects 537 million people. By 2030, this figure is expected to reach 643 million, and by 2045, it will reach 783 million. According to the American Cancer Society, in 2021, 1.9 million new cancer cases will be registered. Therefore, the growing prevalence of chronic diseases such as diabetes and cancer drives the market for single-chamber prefilled syringes.

Competitive Landscape -
Major companies operating in the single-chamber prefilled syringes market include Becton, Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, Weigao Group Medical Polymer Company Limited, Stevanato Group S.p.A., Baxter International Inc., Vetter Pharma International GmbH, Terumo Corporation, Ypsomed Holding AG, SHL Medical AG, Ompi, Elcam Medical A.C.S. Ltd., Oval Medical Technologies Ltd., West Pharmaceutical Services Inc., Gerresheimer Regensburg GmbH, SCHOTT North America Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Aptar Pharma Services Inc., Bespak Europe Ltd., Credence MedSystems Inc., Datwyler Pharma Packaging International Holding AG, Dätwyler Sealing Solutions AG, Fresenius Kabi AG, Haselmeier GmbH, Hikma Pharmaceuticals PLC, HTL-STREFA S.A., Intas Pharmaceuticals Ltd.

Technological Advancements Drive The Evolution Of Single-Chamber Prefilled Syringe Market
Growing technological advancements are shaping the single-chamber prefilled syringe market. Major companies operating in the single-chamber prefilled syringe sector are focused on developing technological solutions for the single-chamber prefilled syringe market to strengthen their position. For instance, in September 2022, Otsuka America Pharmaceutical, Inc., a US-based healthcare company, and H. Lundbeck A/S, a Danish international pharmaceutical company, introduced Aripiprazole 2-month. It comes in a single-chamber, prefilled syringe and is a 2-month, ready-to-use, long-acting injectable form of aripiprazole. The gluteal muscle is where it is to be injected intramuscularly every two months for the dosage.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/single-chamber-prefilled-syringes-global-market-report

Key Segments -

The single-chamber prefilled syringes market covered in this report is segmented -
1) By Type: Glass, Plastic
2) By Application: Vaccine Product, Biologic, Pharmaceutical Product

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

"Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

"Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps"

This release was published on openPR.